Citations

Showing 10 of 108083 citations.

Accuracy of the Lever Sign Test in the Diagnosis of Anterior Cruciate Ligament Injuries
Jarbo, Keith A., Hartigan, David E. , Scott, Kelly, Patel, Karan A. , Scott, Kelly L, Patel, Karan , Jarbo, Keith, Chhabra, Anikar

Mayo Clinic

Orthopaedic Journal of Sports Medicine | October 11, 2017 | Volume: 5 | Issue: 10 | Pages: No page available

10.1177/2325967117729809 | PMID 29051898 Get It

Background: The lever sign test is a new physical examination tool to diagnose anterior cruciate ligament (ACL) tears. Preliminary results suggest almost 100% sensitivity and specificity to diagnose acute and chronic complete ACL tears and clinically significant partial tears as compared with magnetic resonance imaging (MRI). Purpose: To assess the sensitivity and specificity of the lever sign test for the diagnosis of acute ACL injuries, as compared to MRI. We also aimed to determine the accuracy of the lever sign test compared with 3 other tests (anterior drawer, Lachman, and pivot shift) when performed by providers of various training levels, and with the patient awake or under anesthesia. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: We evaluated patients with a chief concern of acute (≤4 weeks) knee pain seen between October 2014 and January 2015, with a thorough history, physical examination, and standard radiographs. MRI was the reference standard; patients without an MRI evaluation were excluded. The 4 physical examination maneuvers were performed on each symptomatic knee during the initial clinic visit (for nonsurgical patients) or under anesthesia in the operating room (for surgical patients) by a randomly assigned undergraduate student, medical student, orthopaedic resident, or orthopaedic fellow. The senior author trained all staff to perform the lever sign test. Statistical analyses were performed. Results: Of 102 patients, 54 were surgical (28 female, 26 male), and 48 were nonsurgical (16 female, 32 male); the mean patient age was 23 years (range, 15-66 years). The overall accuracy of the lever sign test was 77% (63% sensitivity, 90% specificity); the accuracy was similar between patients under anesthesia and awake (77% vs 76%, respectively). There were no significant differences when comparing the sensitivity and specificity of the lever sign test with patients under anesthesia and awake (sensitivity: under anesthesia, 86%, and awake, 68% [ P = .40]; specificity: under anesthesia, 85%, and awake, 96% [ P = .17]). Furthermore, the accuracy of the lever sign test was similar when performed on female versus male patients (75% vs 79%, respectively) or when performed by undergraduate students and medical students compared with orthopaedic residents and fellows (84% vs 88%, respectively). Conclusion: Our study results challenge the exceptional sensitivity and specificity values (both 100%) of the lever sign test, as reported by the original author of the test.
Motor learning guided treatment for acquired apraxia of speech: a case study investigating factors that influence treatment outcomes
Johnson, Rachel K. , Lasker, Joanne P. , Stierwalt, Julie A. G., MacPherson, Megan K. , LaPointe, Leonard L., Johnson, Rachel

Mayo Clinic

Speech, Language and Hearing | October 11, 2017 | Volume: 21 | Issue: 4 | Pages: 213-223

10.1080/2050571x.2017.1388488 Get It

Neuroimaging Correlates of Cerebral Microbleeds
Graff‐Radford, Jonathan , Simino, Jeannette , Kantarci, Kejal , Griswold, Michael , Windham, B. Gwen , Sharrett, A. Richey , Albert, Marilyn S. , Jack, Clifford R. , Vemuri, Prashanthi , Jack, Clifford R , Vemuri, Prashanthi , Kantarci, Kejal , Mosley, Thomas H. , Gottesman, Rebecca F. , Knopman, David S.

Mayo Clinic

Stroke | October 11, 2017 | Volume: 48 | Issue: 11 | Pages: 2964-2972

10.1161/strokeaha.117.018336 | PMID 29018129 Get It

Background and Purpose— Cerebral microbleed (CMB) location (deep versus strictly lobar) may elucidate underlying pathology with deep CMBs being more associated with hypertensive vascular disease and lobar CMBs being more associated with cerebral amyloid angiopathy. The objective of this study was to determine whether neuroimaging signs of vascular disease and Alzheimer pathology are associated with different types of CMBs. Methods— Among 1677 nondemented ARIC (Atherosclerosis Risk in Communities) participants (mean age=76±5 years; 40% men; 26% black) with 3-Tesla MRI scans at the fifth examination (2011–2013), we fit multinomial logistic regression models to quantify relationships of brain volumes (Alzheimer disease signature regions, total gray matter, frontal gray matter, and white matter hyperintensity volumes), infarct frequencies (lacunar, nonlacunar, and total), and apolipoprotein E (number of ε4 alleles) with CMB location (none, deep/mixed, or strictly lobar CMBs). Models were weighted for the sample selection scheme and adjusted for age, sex, education, hypertension, ever smoking status, diabetes mellitus, race site membership, and estimated intracranial volume (brain volume models only). Results— Deep/mixed and strictly lobar CMBs had prevalences of 8% and 16%, respectively. Larger white matter hyperintensity burden, greater total infarct frequency, smaller frontal volumes (in women only), and smaller total gray matter volume were associated with greater risk of both deep and lobar CMBs relative to no CMBs. Greater white matter hyperintensity volume was also associated with greater risk of deep relative to lobar CMBs. Higher lacunar and nonlacunar infarct frequencies were associated with higher risk of deep CMBs, whereas smaller Alzheimer disease signature region volume and apolipoprotein E ε4 homozygosity were associated with greater risk of lobar CMBs. Conclusions— CMBs are a common vascular pathology in the elderly. Markers of hypertensive small-vessel disease may contribute to deep CMBs while cerebral amyloid angiopathy may drive development of lobar CMBs.
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Kumar, Shaji , Gasparetto, Cristina , Vij, Ravi , Pegourié, Brigitte, Benboubker, Lofti, Amiot, Martine , Moreau, Philippe , Punnoose, Elizabeth A. , Alzate, Stefanie, Dunbar, Martin, Xu, Tu , Agarwal, Suresh , Enschede, Sari H., Maciag, Paulo , Verdugo, Maria, Touzeau, Cyrille , Mıkhael, Joseph , Moreau, Philippe , Touzeau, Cyrille , Kaufman, Jonathan L. , Benboubker, Lotfi , Facon, Thierry T.F. , Leverson, Joel D. , Ross, Jeremy A.

Mayo Clinic

Blood | October 10, 2017 | Volume: 130 | Issue: 22 | Pages: 2401-2409

10.1182/blood-2017-06-788786 | PMID 29018077 Get It

Key Points Venetoclax monotherapy at a daily dose up to 1200 mg has an acceptable safety profile in patients with relapsed/refractory MM. Venetoclax monotherapy has demonstrated antimyeloma activity in patients with relapsed/refractory MM positive for t(11;14).
The Influence of Tumor Stage on the Prognostic Value of Ki-67 Index and Mitotic Count in Small Intestinal Neuroendocrine Tumors
Sun, Yu , Lohse, Christine M. , Smyrk, Thomas C. , Hobday, Timothy J. , Kroneman, Trynda, Zhang, Lizhi , Hobday, Timothy

Mayo Clinic

American Journal of Surgical Pathology | October 10, 2017 | Volume: 42 | Issue: 2 | Pages: 247-255

10.1097/pas.0000000000000968 | PMID 29016403 Get It

Tumor cell proliferation rate determined by either Ki-67 index or mitotic count (MC) has shown to be a prognostic factor for gastrointestinal neuroendocrine tumors in general, and after its incorporation in the 2010 World Health Organization tumor grading system, it has become essentially mandatory in pathology reports for all gastrointestinal neuroendocrine tumors, regardless of tumor location. Nevertheless, clinical significance for the Ki-67 index or MC has not been well demonstrated in small intestinal neuroendocrine tumor (SINET), especially those without distant metastasis, the majority of which have very low proliferation rates. We assessed the clinical behavior of 130 SINETs in relation to stage, Ki-67 index, MC, and other pathologic features. Most SINETs (86%) were grade 1 and 14% were grade 2. There were no grade 3 tumors or poorly differentiated neuroendocrine carcinomas. On multivariate analysis, age, Ki-67 index >5%, MC >10/50 high-power field, stage IV, and liver metastases were associated with increased risk of death in all patients. When both stage and grade were considered, Ki-67 index >5% was associated with a nearly 4-fold increased risk of death in stage IV cases (n=60). In contrast, Ki-67 index did not show prognostic value for patients with stages I to III disease (n=70), although MC >1/50 high-power field was significantly associated with death on multivariable analysis. Our study confirms that liver metastasis and increased tumor cell proliferation rate are independent prognostic factors for SINETs, but shows that most SINETs have a very low proliferation rate, which limits its value for predicting tumor behavior. By combining staging and grading information, we demonstrate different roles and cutoff values of Ki-67 index and MC in SINET with different stages.
Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients
Failing, Jarrett, Yan, Yiyi , Porrata, Luis F. , Failing, Jarrett J, Markovic, Svetomir N.

Mayo Clinic

Melanoma Research | October 10, 2017 | Volume: 27 | Issue: 6 | Pages: 596-600

10.1097/cmr.0000000000000404 | PMID 29016387 Get It

The peripheral blood lymphocyte-to-monocyte ratio (LMR) has been associated with prognosis in many malignancies including metastatic melanoma. However, it has not been studied in patients treated with immune checkpoint inhibitors. In this study, we analyzed the baseline LMR with progression-free survival (PFS) and overall survival (OS) in metastatic melanoma patients treated with pembrolizumab. A total of 133 patients with metastatic melanoma treated with pembrolizumab were included in this retrospective study. LMR was calculated from pretherapy peripheral blood counts and the optimal cutoff value was determined by a receiver operator characteristic curve. PFS and OS were evaluated using the Kaplan–Meier method and multivariate Cox proportional hazard modeling. Patients with an LMR of at least 1.7 showed improved PFS (hazard ratio=0.55; 95% confidence interval: 0.34–0.92; P=0.024) and OS (hazard ratio=0.29; 95% confidence interval: 0.15–0.59; P=0.0007). The baseline LMR is associated with PFS and OS in metastatic melanoma patients treated with pembrolizumab, and could represent a convenient and cost-effective prognostic biomarker. Validation of these findings in an independent cohort is needed.
Comparison of Outcomes for Anterior Cervical Discectomy and Fusion With and Without Anterior Plate Fixation
Oliver, Jeremie D. , Goncalves, Sandy, Kerezoudis, Panagiotis , Alvi, Mohammed Ali , Freedman, Brett A. , Bydon, Mohamad , Oliver, Jeremie D , Nassr, Ahmad , Alvi, Mohammed Ali

Mayo Clinic

Spine | October 10, 2017 | Volume: 43 | Issue: 7 | Pages: E413-E422

10.1097/brs.0000000000002441 | PMID 29016435 Get It

Study Design. Systematic review and meta-analysis. Objective. To compare postoperative surgical, radiographic, and patient-reported outcomes following anterior cervical discectomy and fusion (ACDF) with and without plate fixation. Summary of Background Data. ACDF has evolved significantly over the years, including the placement of an anterior plate construct. Although promoting bony osseo-integration at the fusion site, there are a number of plate-related complications that can arise. The non-plating approach is less invasive, however, greater rates of cage subsidence have been associated with this model. Methods. We performed an electronic literature search for human studies that directly compared ACDF with and without anterior plate fixation. Outcomes of interest comprised of postoperative dysphagia, fusion success, and cage subsidence as well as patient reported outcomes, including the Neck Disability Index (NDI) scores and Visual Analog Scale (VAS) for both neck and arm pain. Results. A total of 15 studies (12 observational and 3 randomized controlled trials) and 893 patients (57% males) were included. Overall, ACDF with plate fixation was associated with significantly higher vertebral fusion rates (odds ratio [OR] 1.98; 95% confidence interval [CI] 1.16–3.37), lower subsidence rates (odds ratio [OR] 0.31, 95% CI 0.18–0.52), and more favorable VAS-neck pain scores at last follow-up (mean difference [MD] 0.59, 95% CI −0.78 to −0.41). Conversely, ACDF procedures without plate fixation had marginally better long-term VAS-arm pain scores (mean difference [MD] 0.2, 95% CI 0.04–0.36). No difference was found with regards to dysphagia (OR 1.21, 95% CI, 0.57–2.56) and NDI (MD 0.06, 95% C.I −0.54 to 0.42). Conclusion. Available evidence, although limited, suggests superior surgical outcomes in ACDF procedures with anterior plate fixation (increased fusion, decreased subsidence) and slightly better VAS-neck pain scores at last follow-up. Future longitudinal, multicenter randomized controlled trials should be completed to validate any associations found in this study. Level of Evidence: 3
Test Assembly Implications for Providing Reliable and Valid Subscores
Lee, Minji K. , Sweeney, Kevin P, Melican, Gerald J.

Mayo Clinic

Educational Assessment | October 10, 2017 | Volume: 22 | Issue: 4 | Pages: 205-219

10.1080/10627197.2017.1381552 Get It

Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target
Masyuk, Anatoliy I. , Pisarello, María J. Lorenzo , Ding, Jingyi , Loarca, Lorena, Huang, Bing , Masyuk, Tatyana V. , Lorenzo Pisarello, Maria J, Ding, Jingyi Francess, Huang, Bing Q, LaRusso, Nicholas F.

Mayo Clinic

Hepatology | October 10, 2017 | Volume: 67 | Issue: 3 | Pages: 1088-1108

10.1002/hep.29577 | PMID 29023824 Get It

Polycystic liver disease (PLD) is a group of genetic disorders with limited treatment options and significant morbidity. Hepatic cysts arise from cholangiocytes exhibiting a hyperproliferative phenotype. Considering that hyperproliferation of many cell types is associated with alterations in autophagy, we hypothesized that autophagy is altered in PLD cholangiocytes, contributes to hepatic cystogenesis, and might represent a potential therapeutic target. We employed functional pathway cluster analysis and next‐generation sequencing, transmission electron microscopy, immunofluorescence confocal microscopy, and western blotting to assess autophagy in human and rodent PLD cholangiocytes. A three‐dimensional culture model was used to study the effects of molecular and pharmacologic inhibition of autophagy on hepatic cystogenesis in vitro , and the polycystic kidney disease–specific rat, an animal model of PLD, to study the effects of hydroxychloroquine, a drug that interferes with the autophagy pathway, on disease progression in vivo . Assessment of the transcriptome of PLD cholangiocytes followed by functional pathway cluster analysis revealed that the autophagy–lysosomal pathway is one of the most altered pathways in PLD. Direct evaluation of autophagy in PLD cholangiocytes both in vitro and in vivo showed increased number and size of autophagosomes, lysosomes, and autolysosomes; overexpression of autophagy‐related proteins (Atg5, Beclin1, Atg7, and LC3); and enhanced autophagic flux associated with activation of the cAMP–protein kinase A–cAMP response element–binding protein signaling pathway. Molecular and pharmacologic intervention in autophagy with ATG7 small interfering RNA, bafilomycin A 1 , and hydroxychloroquine reduced proliferation of PLD cholangiocytes in vitro and growth of hepatic cysts in three‐dimensional cultures. Hydroxychloroquine also efficiently inhibited hepatic cystogenesis in the polycystic kidney disease–specific rat. Conclusion: Autophagy is increased in PLD cholangiocytes, contributes to hepatic cystogenesis, and represents a potential therapeutic target for disease treatment. (H epatology 2018;67:1088–1108)
MICRODOSIMETRIC APPLICATIONS IN PROTON AND HEAVY ION THERAPY USING SILICON MICRODOSIMETERS
Chartier, Lachlan, Tran, Linh T. , Bolst, David , Guatelli, Susanna , Pogossov, A, Prokopovich, Dale A., Reinhard, Mark I., Perevertaylo, Vladimir L. , Anderson, Sarah , Beltran, Chris , Matsufuji, Naruhiro, Jackson, Michael , Rosenfeld, Anatoly , Guatelli, S , Rosenfeld, A B , Beltran, Chris J , Anderson, S

Mayo Clinic

Radiation Protection Dosimetry | October 10, 2017 | Volume: 180 | Issue: 1-4 | Pages: 365-371

10.1093/rpd/ncx226 | PMID 29069515 Get It